FAIM
DCOY

Financial Advocates Investment Management’s Decoy Therapeutics DCOY Stock Holding History

Financial Advocates Investment Management’s Portfolio DCOY Stock Details DCOY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Hold
0
– -$2K – 826
2022
Q2 		– Hold
0
– – – 684
2022
Q1 		– Hold
0
– – – 728
2021
Q4 		– Hold
0
– -$12K – 811
2021
Q3 		– Hold
0
– – – 739
2021
Q2 		– Hold
0
– – – 731
2021
Q1 		– Hold
0
– – – 744
2020
Q4 		– Hold
0
– – – 714
2020
Q3 		– Hold
0
– – – 625
2020
Q2 		– Hold
0
– – – 603
2020
Q1 		– Hold
0
– – – 475
2019
Q4 		– Sell
-1
Closed -$160K – 505
2019
Q3 		$119K Buy
+1
New +$341K 0.01% 473

Other funds holding DCOY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
XSC
X-Square Capital Guaynabo, Puerto Rico $297M AUM 32.87% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return
LNWWM
Laird Norton Wetherby Wealth Management San Francisco, California $2.45B AUM